135 related articles for article (PubMed ID: 38039756)
1. ABC transporters are predictors of treatment failure in acute myeloid leukaemia.
Cerovska E; Salek C; Kundrat D; Sestakova S; Pesek A; Brozinova I; Belickova M; Remesova H
Biomed Pharmacother; 2024 Jan; 170():115930. PubMed ID: 38039756
[TBL] [Abstract][Full Text] [Related]
2. ATP-binding casette transporter expression in acute myeloid leukemia: association with in vitro cytotoxicity and prognostic markers.
Varatharajan S; Abraham A; Karathedath S; Ganesan S; Lakshmi KM; Arthur N; Srivastava VM; George B; Srivastava A; Mathews V; Balasubramanian P
Pharmacogenomics; 2017 Feb; 18(3):235-244. PubMed ID: 28112576
[TBL] [Abstract][Full Text] [Related]
3. Coexpression of Multiple ABC-Transporters is Strongly Associated with Treatment Response in Childhood Acute Myeloid Leukemia.
Bartholomae S; Gruhn B; Debatin KM; Zimmermann M; Creutzig U; Reinhardt D; Steinbach D
Pediatr Blood Cancer; 2016 Feb; 63(2):242-7. PubMed ID: 26512967
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of ATP binding cassette transporters is associated with poor prognosis in acute myeloid leukemia.
Liu B; Li LJ; Gong X; Zhang W; Zhang H; Zhao L
Oncol Lett; 2018 May; 15(5):6671-6677. PubMed ID: 29616130
[TBL] [Abstract][Full Text] [Related]
5. Expression profile of stem cell markers and ABC transporters in 5-fluorouracil resistant Hep-2 cells.
Duz MB; Karatas OF
Mol Biol Rep; 2020 Jul; 47(7):5431-5438. PubMed ID: 32627138
[TBL] [Abstract][Full Text] [Related]
6. Isocitrate dehydrogenase 2 inhibitor enasidenib synergizes daunorubicin cytotoxicity by targeting aldo-keto reductase 1C3 and ATP-binding cassette transporters.
Morell A; Budagaga Y; Vagiannis D; Zhang Y; Laštovičková L; Novotná E; Haddad A; Haddad M; Portillo R; Hofman J; Wsól V
Arch Toxicol; 2022 Dec; 96(12):3265-3277. PubMed ID: 35972551
[TBL] [Abstract][Full Text] [Related]
7. ATP Binding Cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients.
Marzac C; Garrido E; Tang R; Fava F; Hirsch P; De Benedictis C; Corre E; Lapusan S; Lallemand JY; Marie JP; Jacquet E; Legrand O
Haematologica; 2011 Sep; 96(9):1293-301. PubMed ID: 21606172
[TBL] [Abstract][Full Text] [Related]
8. Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
Megías-Vericat JE; Montesinos P; Herrero MJ; Moscardó F; Bosó V; Rojas L; Martínez-Cuadrón D; Hervás D; Boluda B; García-Robles A; Rodríguez-Veiga R; Martín-Cerezuela M; Cervera J; Sendra L; Sanz J; Miguel A; Lorenzo I; Poveda JL; Sanz MÁ; Aliño SF
Leuk Lymphoma; 2017 May; 58(5):1197-1206. PubMed ID: 27701910
[TBL] [Abstract][Full Text] [Related]
9. P-gp activity is a critical resistance factor against AVE9633 and DM4 cytotoxicity in leukaemia cell lines, but not a major mechanism of chemoresistance in cells from acute myeloid leukaemia patients.
Tang R; Cohen S; Perrot JY; Faussat AM; Zuany-Amorim C; Marjanovic Z; Morjani H; Fava F; Corre E; Legrand O; Marie JP
BMC Cancer; 2009 Jun; 9():199. PubMed ID: 19549303
[TBL] [Abstract][Full Text] [Related]
10. ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukemia.
Steinbach D; Gillet JP; Sauerbrey A; Gruhn B; Dawczynski K; Bertholet V; de Longueville F; Zintl F; Remacle J; Efferth T
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4357-63. PubMed ID: 16857811
[TBL] [Abstract][Full Text] [Related]
11. Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
Megías-Vericat JE; Martínez-Cuadrón D; Herrero MJ; Rodríguez-Veiga R; Solana-Altabella A; Boluda B; Ballesta-López O; Cano I; Acuña-Cruz E; Cervera J; Poveda JL; Sanz M; Aliño SF; Montesinos P
Leuk Lymphoma; 2021 Mar; 62(3):659-668. PubMed ID: 33135528
[TBL] [Abstract][Full Text] [Related]
12. The FLT3 and PDGFR inhibitor crenolanib is a substrate of the multidrug resistance protein ABCB1 but does not inhibit transport function at pharmacologically relevant concentrations.
Mathias TJ; Natarajan K; Shukla S; Doshi KA; Singh ZN; Ambudkar SV; Baer MR
Invest New Drugs; 2015 Apr; 33(2):300-9. PubMed ID: 25597754
[TBL] [Abstract][Full Text] [Related]
13. Promoter methylation patterns of ABCB1, ABCC1 and ABCG2 in human cancer cell lines, multidrug-resistant cell models and tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.
Spitzwieser M; Pirker C; Koblmüller B; Pfeiler G; Hacker S; Berger W; Heffeter P; Cichna-Markl M
Oncotarget; 2016 Nov; 7(45):73347-73369. PubMed ID: 27689338
[TBL] [Abstract][Full Text] [Related]
14. Update on drug transporter proteins in acute myeloid leukemia: Pathological implication and clinical setting.
Vasconcelos FC; de Souza PS; Hancio T; de Faria FCC; Maia RC
Crit Rev Oncol Hematol; 2021 Apr; 160():103281. PubMed ID: 33667660
[TBL] [Abstract][Full Text] [Related]
15. The role of ATP-binding cassette transporter genes in the progression of prostate cancer.
Karatas OF; Guzel E; Duz MB; Ittmann M; Ozen M
Prostate; 2016 Apr; 76(5):434-44. PubMed ID: 26708806
[TBL] [Abstract][Full Text] [Related]
16. Expression of ABCB1, ABCC1 and 3 and ABCG2 in glioblastoma and their relevance in relation to clinical survival surrogates.
Roy LO; Lemelin M; Blanchette M; Poirier MB; Aldakhil S; Fortin D
J Neurooncol; 2022 Dec; 160(3):601-609. PubMed ID: 36342588
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal study of ABC transporter expression in canine multicentric lymphoma.
Zandvliet M; Teske E; Schrickx JA; Mol JA
Vet J; 2015 Aug; 205(2):263-71. PubMed ID: 25475167
[TBL] [Abstract][Full Text] [Related]
18. Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro.
Cihalova D; Staud F; Ceckova M
Cancer Chemother Pharmacol; 2015 Jul; 76(1):105-16. PubMed ID: 25986678
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometry-based assessment of mitoxantrone efflux from leukemic blasts varies with response to induction chemotherapy in acute myeloid leukemia.
Kim HP; Bernard L; Berkowitz J; Nitta J; Hogge DE
Cytometry B Clin Cytom; 2012 Sep; 82(5):283-94. PubMed ID: 22508650
[TBL] [Abstract][Full Text] [Related]
20. Leukemia and ABC transporters.
Fukuda Y; Lian S; Schuetz JD
Adv Cancer Res; 2015; 125():171-96. PubMed ID: 25640270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
